Jan 08, 2024 / 10:15PM GMT
David A. Low - JPMorgan Chase & Co, Research Division - Research Analyst
Hello, everyone. My name is David Low and I cover health care in Australia for JPMorgan. This afternoon, we've got Mick Farrell, CEO of ResMed. Glad to have you, Mick.
Michael J. Farrell - ResMed Inc. - CEO & Chairman
Thanks, David, and thanks, everyone, for joining us. You can read through our disclaimers on our website. And I'm here -- if you're a speed reader, then I'll move through ResMed at a glance. So ResMed is the global leader in respiratory medicine. ResMed stands for respiratory medicine. We're also the global leader in residential care. We make the smallest, the quietest, the most comfortable and most cloud connected and most intelligent therapies on the planet.
We are the global leader in digital health solutions with over 22.5 million 100% cloud-connectable medical devices, selling in over 140 countries worldwide. And we have an asset that's a lot more valuable than our $25 billion market cap, which is 16 billion nights of medical data in the cloud. We
Resmed Inc at JPMorgan Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers